StonvexLoading…
StonvexStonvexStonvexCore line items from CRTO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.94B | $1.93B | $1.95B | $2.02B |
Operating Income | $202.76M | $151.40M | $77.22M | $24.28M |
Net Income | $144.60M | $111.57M | $53.26M | $8.95M |
EPS (Diluted) | $2.64 | $1.90 | $0.88 | $0.14 |
Total Assets | $2.20B | $2.27B | $2.39B | $2.35B |
Total Liabilities | $1.02B | $1.19B | $1.28B | $1.27B |
Cash & Equivalents | $342.04M | $290.69M | $336.34M | $348.20M |
Free Cash Flow OCF − CapEx | $208.50M | $180.05M | $108.13M | $192.17M |
Shares Outstanding | 51.15M | 54.28M | 61.17M | 63.25M |